Argus: Anthrax Vaccine Maker Emergent BioSolutions Poised For Earnings Growth
Emergent Biosolutions Inc (NYSE: EBS), a maker of vaccines and products for infectious diseases as well as chemical, biological or nuclear attacks, picked up a sell-side bull Wednesday. Latest Ratings for EBS Da.....»»
Emergent BioSolutions announces five-year growth strategy
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q3 2019 Results - Earnings Call Transcript
Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q3 2019 Results - Earnings Call Transcript.....»»
Analysts Say Additional Fastenal Upside Is Limited Following Earnings Pop
Fastenal Company (NASDAQ: FAST) shares jumped 17.2% to a new all-time high on Friday after the company reported earnings and revenue beats. The construction equipment maker reported 7.8% sales growth, while gross margins dropped fr.....»»
Emergent BioSolutions" chikungunya vaccine receives EMA prime designation
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sonim Technologies: Busted IPO Rugged Phone Maker Poised For Growth - $15 Price Target
Sonim Technologies: Busted IPO Rugged Phone Maker Poised For Growth - $15 Price Target.....»»
Wells Fargo Upgrades Emergent Biosolutions After Smallpox Vaccine Announcement
Emergent Biosolutions I.....»»
Bank of America Looks Poised for Sluggish Earnings and Margin Compression
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Subdued revenue growth and net inte.....»»
Emergent BioSolutions, Inc. (EBS) CEO Bob Kramer on Q2 2019 Results - Earnings Call Transcript
Emergent BioSolutions, Inc. (EBS) CEO Bob Kramer on Q2 2019 Results - Earnings Call Transcript.....»»
Ericsson second-quarter operating profit matches expectations
Mobile telecom equipment maker Ericsson reported on Wednesday a rise in line with expectations in second-quarter operating earnings helped by strong sales growth in North America......»»
Fantastic Plastic: Berry Global Analyst Sees Solid Earnings Growth Prospects
Berry Global Group, Inc. (NYSE: BERY) is poised for robust earnings and free cash flow growth in coming years, driven mostly by the acquisition of RPC Group, ac.....»»
5 Must-Buy Stocks Ahead of Q2 Earnings Despite Growth Fears
It will be prudent to invest in those stocks that skyrocketed in the past three months with a favorable Zacks Rank and are poised to beat on second-quarter earnings. Want the latest recommendation.....»»
Emergent BioSolutions announces FDA approval for Cholera vaccine changes
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Glaxo (GSK) Beats on Q1 Earnings & Sales, Shingrix Impresses
Glaxo (GSK) beats earnings and sales estimates for the first quarter. Strong sales growth of vaccine portfolio boosts sales. However, Advair.....»»
Hasbro Earnings Are Back on the Growth Track; Stock Soars 14%
The toy maker's results suggest that it's shed the Toys R Us blues......»»
Ericsson first-quarter operating profit beats forecast
Mobile telecom equipment maker Ericsson reported on Wednesday a bigger that expected rise in first-quarter operating earnings and said it saw strong growth in North America as it raised its outlook for the global networks market......»»
Emergent"s (EBS) Strong Vaccine Portfolio to Fuel Growth
Emergent's (EBS) vaccine portfolio looks promising. The company's rece.....»»
3 Tech Stocks to Buy for Long-Term Earnings Growth
No matter how long the market rally lasts, it is always a good idea to search for companies that look poised to post solid long-term earnings growth, as positive earnings growth is one of the better indicators of rising stock prices......»»
CCL maker TUC reports robust earnings growth for 2018
Copper clad laminate (CCL) maker Taiwan Union Technology (TUC) has reported robust earnings growth for 2018 on increased shipments of CCL products to the networking device and server sectors......»»
Emergent Begins Phase III Study on Anthrax Vaccine AV7909
Emergent (EBS) kicks off a late-stage study on its inves.....»»